Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Total 13F shares
-
7,020,367
-
Share change
-
-95,561
-
Total reported value
-
$77,139,761
-
Put/Call ratio
-
136%
-
Price per share
-
$11.11
-
Number of holders
-
59
-
Value change
-
-$2,020,205
-
Number of buys
-
32
-
Number of sells
-
19
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q1 2015
As of 31 Mar 2015 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,020,367 shares of stock of the company.
Largest 10 holders included Novo A/S, EAGLE ASSET MANAGEMENT INC, FMR LLC, RA CAPITAL MANAGEMENT, LLC, HealthCor Management, L.P., BlackRock Fund Advisors, VANGUARD GROUP INC, EMERALD MUTUAL FUND ADVISERS TRUST, BALYASNY ASSET MANAGEMENT LLC, and STATE STREET CORP.
This table shows 59 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.